Evidence map›Paper›PMID 42876705›Full record

ArticleFrontiers in cellular and infection microbiology2026

Genomic and antimicrobial susceptibility characterization of a clinical

Ying Chen, Gerrit Brandis, Hong Li, Yongjun Luo, Huiyu Wang, Jinrong He, Yumeng Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying Chen *Laboratory Department, Qionghai People's Hospital, Qionghai, Hainan, China.
Gerrit Brandis *Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Hong LiLaboratory Department, Qionghai People's Hospital, Qionghai, Hainan, China.
Yongjun LuoXinjiang Uygur Autonomous Region Center for Disease Control and Prevention, Urumqi, China.
Huiyu WangLaboratory Department, Qionghai People's Hospital, Qionghai, Hainan, China.
Jinrong HeNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yumeng WangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We sequenced the complete genome of the clinical Results: The genome of strain 21PA20240911 was 2.3Mbp with a G+C content of 40.84%. ANI analysis confirmed its taxonomic assignment as Conclusion: This study provides the first complete genome sequence of a clinical

Indexed as

Anti-Bacterial AgentsGenome, BacterialPasteurellaPasteurella InfectionsAnimalsBase CompositionChinaDrug Resistance, BacterialGenomicsHumansMicrobial Sensitivity TestsPhylogenySequence Analysis, DNAUrinary Tract InfectionsVirulence FactorsWhole Genome SequencingAnti-Bacterial AgentsVirulence Factorsantimicrobial susceptibilityfunction analysisgenomic featuresOne HealthPasteurella aerogeneswhole genome sequencing

Identifiers

PMID42876705
PMCPMC13661337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.